BioMarin製藥BMRN
那斯達克 · USD
52.99
-0.71
(-1.32%)
收盤 12/12 04:59 (UTC+8)
盤後
52.88
52.88
(-0.21%)
12/12 04:59 (UTC+8)
BioMarin製藥BMRN
52.99
-0.71
(-1.32%)
財務數據
損益表
- 5.95
- 5.81
- 6.46
- 6.49
- 7.12
- 7.46
- 7.47
- 7.45
- 8.25
- 7.76
- -0.19
- -2.34
- 11.16
- 0.41
- 9.74
- 4.73
- 0.21
- -0.29
- 10.77
- -5.97
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | |
營業收入淨額 | 776,133 | 825,410 | 745,145 | 747,313 | 745,740 | 712,029 | 648,833 | 646,207 | 581,329 | 595,275 |
營業成本 | 140,085 | 150,090 | 151,558 | 136,139 | 188,457 | 130,459 | 125,180 | 120,722 | 113,285 | 119,159 |
營業毛利 | 636,048 | 675,320 | 593,587 | 611,174 | 557,283 | 581,570 | 523,653 | 525,485 | 468,044 | 476,116 |
營業費用 | 682,740 | 398,433 | - | 449,767 | 443,390 | 461,118 | - | 525,883 | 452,136 | 420,303 |
研發費用 | 409,478 | 161,308 | 158,731 | 173,509 | 184,901 | 183,787 | 204,987 | 206,250 | 191,314 | 177,363 |
推銷及管理費用 | 268,415 | 232,279 | 206,116 | 266,607 | 253,480 | 263,032 | 225,906 | 304,397 | 245,141 | 227,316 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 4,847 | 4,846 | 4,847 | 9,651 | 5,009 | 14,299 | 14,298 | 15,236 | 15,681 | 15,624 |
營業利益 | -46,692 | 276,887 | 223,893 | 161,407 | 113,893 | 120,452 | 88,462 | -398 | 15,908 | 55,813 |
其他收入及費用 | 22,947 | 23,660 | 17,059 | 10,809 | 23,516 | 15,258 | 30,632 | 25,823 | 29,540 | 18,752 |
利息費用 | 2,579 | 2,679 | 2,863 | 2,577 | 2,968 | 3,574 | 3,547 | 6,098 | 3,779 | 3,755 |
稅前純益 | -26,324 | 297,868 | 238,089 | 169,639 | 134,441 | 132,136 | 105,547 | 19,327 | 41,669 | 70,810 |
所得稅 | 4,420 | 57,336 | 52,403 | 44,696 | 28,361 | 24,962 | 16,885 | -1,048 | 1,291 | 14,770 |
稅後純益 | -30,744 | 240,532 | 185,686 | 124,943 | 106,080 | 107,174 | 88,662 | 20,375 | 40,378 | 56,040 |
基本每股稅後盈餘(元) | -0.16 | 1.25 | 0.97 | 0.66 | 0.56 | 0.56 | 0.47 | 0.11 | 0.21 | 0.30 |
稀釋每股稅後盈餘(元) | -0.15 | 1.24 | 0.95 | 0.65 | 0.55 | 0.55 | 0.46 | 0.10 | 0.21 | 0.29 |
基本平均股數(千股) | 192032.00 | 191907.00 | 190967.00 | 190688.00 | 190429.00 | 190114.00 | 188866.00 | 188479.00 | 188219.00 | 187948.00 |
稀釋平均股數(千股) | 192032.00 | 197091.00 | 196474.00 | 196581.00 | 197147.00 | 200505.00 | 199262.00 | 191838.00 | 191173.00 | 194998.00 |
還原基本每股稅後盈餘(元) | -0.16 | 1.25 | 0.97 | 0.66 | 0.56 | 0.56 | 0.47 | 0.11 | 0.21 | 0.30 |
還原稀釋每股稅後盈餘(元) | -0.15 | 1.24 | 0.95 | 0.65 | 0.55 | 0.55 | 0.46 | 0.10 | 0.21 | 0.29 |
還原基本平均股數(千股) | 192,032 | 191,907 | 190,967 | 190,688 | 190,429 | 190,114 | 188,866 | 188,479 | 188,219 | 187,948 |
還原稀釋平均股數(千股) | 192,032 | 197,091 | 196,474 | 196,581 | 197,147 | 200,505 | 199,262 | 191,838 | 191,173 | 194,998 |
EBITDA(千元) | -6,236 | 317,755 | 261,659 | 194,097 | 154,474 | 159,997 | 133,942 | 49,839 | 68,885 | 97,421 |